Ignite Creation Date:
2024-05-06 @ 3:59 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04825327
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-08
First Post:
2021-03-28
Brief Title:
Predicting the Future Incipient Tuberculosis
Sponsor:
Organization:
Amsterdam Institute for Global Health and Development
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
12 Months
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Fingerprick blood for point-of-care testing two serum tubes one Tempus RNA tube urine 30ml and sputum max 3 sputa will be collected from cohort participants who are TB presumptive or meeting sputum expectorator definition
Enrollment Count:
3016
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 74254 |
Who Masked List: